The market growth is largely driven by factors such as growing to fund for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers.
The medical application segment will grow at the highest CAGR in the cell counting market. Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment during the forecast period.
The large growth of this segment can be attributed to factors such as the growing number of proteomics, genomics, and stem cell research activities; increasing research funding; increasing investments by pharmaceutical and biotechnology companies; and the growing trend of research infrastructure modernization.
For More information Download the PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728
The hospitals and diagnostic laboratories will grow at the highest CAGR during the forecast period. The high growth of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R&D expenditure, and commercial expansion of various pharmaceutical companies.
Key Market Players
The major companies in the cell counting market include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US).
The consumables segment dominated the market in 2019 and is also expected to be the fastest-growing segment during the forecast period. By type, the media, sera, and reagents segment accounted for the largest share of the cell counting consumables market in 2019. The large share and high growth of the consumables segment can primarily be attributed to the frequent purchase of these products as compared to instruments, which are considered one-time investments.
Research Developments:
- In 2020, Danaher (US) acquired the Biopharma business of GE Life Sciences, GE Healthcare. This business will be established as a standalone operating company with Danaher’s Life Science segment.
- In 2019, Agilent Technologies acquired BioTek Instruments, Inc. (US). This acquisition will strengthen Agilent Technologies' position in the cell counting market.
- In 2019, Perkin Elmer entered into an agreement with Accenture to join Accenture’s Open Partner Ecosystem Program to help researchers accelerate drug discovery and improve patient outcomes.
The market growth is largely driven by factors such as growing to fund for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers.
On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.
Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment during the forecast period.
The high growth of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R expenditure, and commercial expansion of various pharmaceutical companies.
For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728 The large growth of this segment can be attributed to factors such as the growing number of proteomics, genomics, and stem cell research activities; increasing research funding; increasing investments by pharmaceutical and biotechnology companies; and the growing trend of research infrastructure modernization.
In 2019, research institutes accounted for the largest share of the market.
Cell Counting Industry Overview:Goal to offer most segmented consumption and sales data of several types of Cell Counting Market, downstream consumption fields, and competitive landscape in numerous regions and countries around the globe, this report studies the latest upcoming market data from the primary and secondary authoritative foundation.The market is fueled to grow due to various factors in the American, European, and APAC regions.
However, the Middle East and African markets are yet to be explored by the market players.
The Middle East and African regional market are lagging owing to a lack of awareness among researchers, high cost of instruments and consumables among other factors.
However, the regions of Africa are burdened with the disease caused by a virus, bacteria, and parasites, such as malaria, dengue, swine flu, and influenza where the market products provide huge support in diagnostics.
Thus, these present a lucrative opportunity for the market players in these regions.The report also suggests the latest market dynamics, such as key driving factors, key restraining factors, and industry news such as mergers, acquisitions, and investments.
It provides market size (value and volume), industry share, market growth rate by types, applications, end-user and combines both qualitative and quantitative techniques to make micro and macro predictions in numerous regions or countries in the world.The global cell counting market valued at USD 9765.2 million in 2019 and is expected to grow at a 6.5% CAGR during the forecast period.Our Report Will Help You Find What You Looking for.
The global cell counting market is projected to reach USD 14.5 billion in 2025 from USD 10.4 billion in 2020, at a CAGR of 6.7 % during the forecast period.Cell Counting Market growth is largely driven by factors such as growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers.On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.By application, the research application segment accounted for the largest share of the cell counting market On the basis of application, the cell counting market is segmented into research, medical, and industrial applications.
In 2019, research applications accounted for the largest share of the market.
Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728By end user, the research institutes segment accounted for the largest share of the cell counting market On the basis of end users, the cell counting market is segmented into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and CROs, and other end users.
In 2019, research institutes accounted for the largest share of the market.
The large share of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R expenditure, and commercial expansion of various pharmaceutical companies.By region, North America accounted for the largest share of the cell counting market In 2019, North America accounted for the largest share of the cell counting consumables market, followed by Europe.
The large share of the North American market can be attributed to the increasing demand for technologically advanced instruments in research and diagnostic applications and the high prevalence of target conditions, coupled with the increasing demand for early and effective disease diagnosis and treatment.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728Leading Players The major companies in the cell counting market include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US)
